Cochrane Abstracts
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus Addition of Long‐acting Beta2‐agonists (LABA) for Adults With Asthma." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma. Accessed December 10, 2024.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma
Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus Addition of Long‐acting Beta2‐agonists (LABA) for Adults With Asthma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma
ID - 432748
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
